1. Home
  2. SFWL vs MCRB Comparison

SFWL vs MCRB Comparison

Compare SFWL & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shengfeng Development Limited

SFWL

Shengfeng Development Limited

HOLD

Current Price

$0.80

Market Cap

72.7M

Sector

Industrials

ML Signal

HOLD

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$5.12

Market Cap

71.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFWL
MCRB
Founded
2001
2010
Country
China
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.7M
71.0M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
SFWL
MCRB
Price
$0.80
$5.12
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$14.00
AVG Volume (30 Days)
15.8K
131.7K
Earning Date
03-27-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$789,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$5.00
52 Week High
$1.29
$29.98

Technical Indicators

Market Signals
Indicator
SFWL
MCRB
Relative Strength Index (RSI) 47.08 34.03
Support Level $0.59 N/A
Resistance Level $1.03 $9.53
Average True Range (ATR) 0.08 0.57
MACD -0.00 -0.19
Stochastic Oscillator 63.70 6.77

Price Performance

Historical Comparison
SFWL
MCRB

About SFWL Shengfeng Development Limited

Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services. The company's operations are based in the PRC. Its integrated logistics solutions are comprised of three business streams: B2B freight transportation services; cloud storage services; and value-added services. The company derives maximum revenue from Transportation, followed by Warehouse storage management services. The solutions provides by the company are : Internet TV; Electronic communication; Textiles and Apparel; Automotive parts; and e-commerce.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Share on Social Networks: